Matches in Wikidata for { <http://www.wikidata.org/entity/Q83346533> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q83346533 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q83346533 description "im Januar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83346533 description "scientific article published on 27 January 2012" @default.
- Q83346533 description "wetenschappelijk artikel" @default.
- Q83346533 description "наукова стаття, опублікована в січні 2012" @default.
- Q83346533 name "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 name "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 type Item @default.
- Q83346533 label "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 label "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 prefLabel "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 prefLabel "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 P1433 Q83346533-5B4682F6-6135-4F3A-AD85-E88459E42C80 @default.
- Q83346533 P1476 Q83346533-121BD3DA-3138-43C4-89BF-FF0281FBE58B @default.
- Q83346533 P2093 Q83346533-03FF601B-9646-4602-8F96-FE20791140C8 @default.
- Q83346533 P2093 Q83346533-48751946-73F8-4BB2-8AF3-73F76EA51255 @default.
- Q83346533 P2093 Q83346533-89D1C2D2-BB2E-401E-ADF6-82A4A31157F3 @default.
- Q83346533 P2093 Q83346533-BAEAC1BD-2536-4CAA-9B65-C348CF032AA9 @default.
- Q83346533 P2093 Q83346533-D2BCDD4B-7B21-4E76-A187-B32330E1184B @default.
- Q83346533 P2093 Q83346533-DEAC8705-77A7-4320-ACC1-3BC2939B39AA @default.
- Q83346533 P2093 Q83346533-F2868FE9-12C7-48F4-B1D7-8DDCDEAF5214 @default.
- Q83346533 P304 Q83346533-43D94314-1B39-4A65-A9AD-90086B402547 @default.
- Q83346533 P31 Q83346533-089A9ABD-EA6C-4074-A300-587923AE4D1C @default.
- Q83346533 P356 Q83346533-AA03106C-FB7D-434C-9B9E-8B02790BA1EA @default.
- Q83346533 P433 Q83346533-71D056FC-0C01-4C56-8476-43C8F67E297B @default.
- Q83346533 P478 Q83346533-C31D51F7-D09E-4FD0-B248-8BF799041196 @default.
- Q83346533 P50 Q83346533-165C3882-0139-4EC0-A08F-FC753D908E41 @default.
- Q83346533 P50 Q83346533-8EA2E13F-E57E-4D86-A5E6-7CC97036DE13 @default.
- Q83346533 P577 Q83346533-6145A7EC-ADDB-4E19-A741-E9F93FBD2D6B @default.
- Q83346533 P698 Q83346533-91987E74-97FD-48A0-BF9F-99570538AFB7 @default.
- Q83346533 P921 Q83346533-224EC844-B496-456B-A50B-E424C4814CC9 @default.
- Q83346533 P356 J.THROMRES.2011.12.038 @default.
- Q83346533 P698 22285300 @default.
- Q83346533 P1433 Q15758741 @default.
- Q83346533 P1476 "Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade" @default.
- Q83346533 P2093 "Charlotte Grosdidier" @default.
- Q83346533 P2093 "Franck Paganelli" @default.
- Q83346533 P2093 "Jacques Bessereau" @default.
- Q83346533 P2093 "Julien Mancini" @default.
- Q83346533 P2093 "Laurence Camoin-Jau" @default.
- Q83346533 P2093 "Laurent Bonello" @default.
- Q83346533 P2093 "Michel Ostorero" @default.
- Q83346533 P304 "70-74" @default.
- Q83346533 P31 Q13442814 @default.
- Q83346533 P356 "10.1016/J.THROMRES.2011.12.038" @default.
- Q83346533 P433 "1" @default.
- Q83346533 P478 "130" @default.
- Q83346533 P50 Q61874319 @default.
- Q83346533 P50 Q90362010 @default.
- Q83346533 P577 "2012-01-27T00:00:00Z" @default.
- Q83346533 P698 "22285300" @default.
- Q83346533 P921 Q410237 @default.